Abstract
Autoimmune thyroid diseases (AITD) are a group of diseases with significant different clinical manifestation,but with similar genetic and immunologic background.Thyrotropin receptor antibody (TRAb) has significance in the diagnosis and prediction of prognosis for Graves' disease (GD) and Graves'ophthalmopathy (GO).Anti-thyroperoxidase antibody (TPOAb) and anti-thyroglobulin antibody are hallmark of autoimmune thyroiditis (AIT).The therapies for GD are mainly to control the hyperthyroidism.Immunosuppressive therapy is used for sever GO.Up to date,evidence-based medical evidence has demonstrated that treatment using selenium could decrease the level of TPOAb in the patients with AIT.The immune therapies to the pathogenesis of AITD still need to be developed and supported by clinical evidence. Key words: Autoimmune (thyroid) diseases ; Graves' disease; Graves' ophthalmopathy; Autoimmune thyroiditis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
